公司资料
Simulations Plus 股价、新闻与催化剂
- 股票代码:
- SLP
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
18.40 USD (0.00%)
收盘价
最后更新: 2026年8月24日
339M USD
市值
股价为何变动
As of Aug 24, 2026, SLP was little changed and closed at $18.40. No new same-company headline was identified in the current news window.
公司概览
业务概览
Simulations Plus is a software company that provides modeling, simulation, and workflow tools for drug development. Its value lies in helping biopharma customers make better development decisions.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Simulations Plus sits in pharma software and development tools.
商业模式特征
The company depends on software subscriptions, services, and continued adoption by drug developers and regulators.
生物医药行业定位
Simulations Plus is an important biotech-enabling software name, not a drug company itself.
未来催化剂
- Simulations Plus's catalysts are software bookings, biosimulation demand, and AI-driven workflow adoption in pharma development. Investors will want to see whether the modeling platform stays embedded in drug development workflows.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。